1
|
Aass KR, Mjelle R, Kastnes MH, Tryggestad SS, van den Brink LM, Aass Roseth I, Westhrin M, Zahoor M, Moen SH, Vikene Nedal TM, Buene G, Misund K, Sponaas AM, Ma Q, Sundan A, Groen RW, Slørdahl TS, Waage A, Standal T. Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells. iScience 2022; 25:103605. [PMID: 35005550 PMCID: PMC8717606 DOI: 10.1016/j.isci.2021.103605] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2021] [Revised: 10/13/2021] [Accepted: 12/08/2021] [Indexed: 02/06/2023] Open
Abstract
Interleukin-32 (IL-32) is a nonclassical cytokine expressed in cancers, inflammatory diseases, and infections. Its expression is regulated by two different oxygen sensing systems; HIF1α and cysteamine dioxygenase (ADO), indicating that IL-32 may be involved in the response to hypoxia. We here demonstrate that endogenously expressed, intracellular IL-32 interacts with components of the mitochondrial respiratory chain and promotes oxidative phosphorylation. Knocking out IL-32 in three myeloma cell lines reduced cell survival and proliferation in vitro and in vivo. High-throughput transcriptomic and MS-metabolomic profiling of IL-32 KO cells revealed that cells depleted of IL-32 had perturbations in metabolic pathways, with accumulation of lipids, pyruvate precursors, and citrate. IL-32 was expressed in a subgroup of myeloma patients with inferior survival, and primary myeloma cells expressing IL-32 had a gene signature associated with immaturity, proliferation, and oxidative phosphorylation. In conclusion, we demonstrate a previously unrecognized role of IL-32 in the regulation of plasma cell metabolism. Intracellular IL-32 is an endogenous growth factor for malignant plasma cells IL-32 interacts with components of the electron transport chain IL-32 promotes oxidative phosphorylation IL-32 is expressed by immature, CD45 + highly proliferating malignant plasma cells
Collapse
Affiliation(s)
- Kristin Roseth Aass
- Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.,Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway
| | - Robin Mjelle
- Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway
| | - Martin H Kastnes
- Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.,Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway
| | - Synne S Tryggestad
- Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.,Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway
| | - Luca M van den Brink
- Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway
| | - Ingrid Aass Roseth
- Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.,Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway
| | - Marita Westhrin
- Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway
| | - Muhammad Zahoor
- Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo 0372, Norway
| | - Siv H Moen
- Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.,Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway
| | - Tonje M Vikene Nedal
- Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.,Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway
| | - Glenn Buene
- Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.,Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway
| | - Kristine Misund
- Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway
| | - Anne-Marit Sponaas
- Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway
| | - Qianli Ma
- Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.,Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway
| | - Anders Sundan
- Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.,Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway
| | - Richard Wj Groen
- Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam 1081, the Netherlands
| | - Tobias S Slørdahl
- Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway.,Department of Hematology, St.Olavs University Hospital, Trondheim 7491, Norway
| | - Anders Waage
- Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway.,Department of Hematology, St.Olavs University Hospital, Trondheim 7491, Norway
| | - Therese Standal
- Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.,Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway.,Department of Hematology, St.Olavs University Hospital, Trondheim 7491, Norway
| |
Collapse
|